Cadmium Toxicity: Sources, Health Effects, and Prevention

Table of Contents

  1. Overview
  2. Sources of Exposure
  3. Toxicokinetics
  4. Mechanism of Toxicity
  5. Health Effects
  6. Diagnosis
  7. Treatment
  8. Prevention
  9. Related Topics
  10. References

1. Overview

Cadmium (Cd) is a soft, silvery-white heavy metal classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen — definitively carcinogenic to humans — based on evidence for lung cancer from occupational inhalation exposure and associations with kidney and prostate cancer. It is a byproduct of zinc, lead, and copper mining and smelting, and enters the human food chain primarily through contaminated soil and phosphate fertilizers.

The most dramatic historical demonstration of chronic cadmium toxicity is itai-itai disease (Japanese: "ouch-ouch disease"), first recognized in the Jinzu River basin of Toyama Prefecture, Japan, during the 1910s–1940s. Cadmium released from upstream zinc mining operations contaminated rice paddies through irrigation water. Residents — predominantly postmenopausal, multiparous women with nutritional deficiencies — developed severe osteomalacia and pathological fractures of the spine and limbs. The disease was formally linked to cadmium contamination in 1968 and is considered a landmark case in environmental medicine.

What makes cadmium uniquely dangerous is its extraordinarily long biological half-life. Unlike lead, which is stored in bone but can be partially mobilized and excreted, cadmium accumulates relentlessly in the kidneys over decades with an estimated biological half-life of 10–30 years and essentially no effective natural excretion pathway. The kidney burden of cadmium at death reflects virtually the entire lifetime intake. Damage to the kidney, once established, is largely irreversible.

The European Food Safety Authority (EFSA) and WHO have identified dietary intake as the dominant exposure route for the general population, and have established tolerable weekly intakes, though some population subgroups — particularly smokers, vegetarians with high root vegetable intake, and women with low iron stores — may routinely exceed these thresholds.

Back to Table of Contents

2. Sources of Exposure

Cigarette Smoke: The Dominant Non-Occupational Source

Cigarette smoking is the single most important source of cadmium exposure for the general non-occupationally exposed population. Tobacco plants are highly efficient cadmium accumulators; cadmium concentrations in tobacco are typically 1–2 µg per cigarette. Combustion produces cadmium-containing particles that are efficiently absorbed through the pulmonary alveoli at approximately 10–40% efficiency — far higher than gastrointestinal absorption. A pack-a-day smoker may absorb more cadmium from smoking alone than from all dietary sources combined. Blood cadmium levels in smokers are typically 4–7 times higher than in non-smokers.

Dark Chocolate and Cocoa

Dark chocolate and cocoa-based products can contain significant cadmium, absorbed by cacao trees from soils in Latin America (particularly Ecuador and Peru) where volcanic soils are naturally cadmium-rich. A 2023 Consumer Reports investigation found that some dark chocolate products contained cadmium levels exceeding California's Proposition 65 threshold with daily consumption. Because dark chocolate is frequently promoted as a health food and consumed in quantity, cadmium exposure from this source deserves attention.

Leafy Vegetables and Spinach

Leafy green vegetables — particularly spinach, lettuce, and Swiss chard — are among the highest dietary cadmium contributors due to efficient uptake from soil through plant roots. In populations with high leafy green consumption, vegetables may be a larger cadmium source than grains. Organic produce grown on historically contaminated soils is not necessarily lower in cadmium than conventionally grown produce.

Rice

Rice is a major dietary cadmium source in Asian populations. Cadmium accumulates preferentially in rice grain, particularly in flooded (anaerobic) paddy conditions that promote cadmium solubility. In Japan, itai-itai disease was directly attributed to cadmium-contaminated rice. Regulatory limits for cadmium in rice exist in the European Union (0.20 mg/kg), Japan (0.40 mg/kg), and elsewhere, but enforcement varies globally. Brown rice contains more cadmium than white rice due to the bran layer.

Shellfish and Crustaceans

Bivalve shellfish — particularly oysters, clams, mussels, and scallops — bioconcentrate cadmium from seawater and sediment. Crustaceans (lobster, crab, shrimp) also accumulate cadmium in hepatopancreatic tissue. Regular consumption of shellfish can contribute substantially to dietary cadmium intake, particularly in coastal populations with high shellfish consumption.

Phosphate Fertilizers

Phosphate rock used to manufacture agricultural fertilizers contains naturally occurring cadmium, which is transferred to agricultural soils with repeated application. Over decades, cadmium accumulates in topsoil, increasing cadmium concentrations in food crops. This is a global issue affecting farmlands in North America, Europe, Australia, and elsewhere. The European Union has enacted regulations to cap cadmium content in phosphate fertilizers (60 mg Cd/kg P2O5, with plans to tighten limits).

Nickel-Cadmium Batteries

Rechargeable nickel-cadmium (NiCd) batteries contain approximately 15–18% cadmium by weight. Improper disposal leads to cadmium leaching into soil and groundwater near landfills. While largely replaced by nickel-metal hydride and lithium-ion batteries in consumer electronics, NiCd batteries remain in use in power tools and some industrial applications. Battery recycling is regulated under the EU Battery Directive and U.S. state laws.

Occupational Exposure

Workers in zinc and lead smelting, cadmium refining, nickel-cadmium battery production, electroplating, and pigment manufacturing face the highest occupational exposures. Welding and cutting of cadmium-coated metals or cadmium-containing alloys generates cadmium oxide fumes with acute inhalation toxicity. OSHA's Cadmium Standard (29 CFR 1910.1027) mandates air monitoring, biological surveillance, and medical removal protections for exposed workers. Cadmium was also historically used as a yellow/orange pigment (cadmium sulfide) in paints and ceramics — still present in some artist paints.

Back to Table of Contents

3. Toxicokinetics

Absorption

Gastrointestinal absorption of cadmium averages 3–8% in adults under normal nutritional conditions, substantially lower than pulmonary absorption from inhalation (10–40%). However, absorption increases dramatically under conditions of iron deficiency (cadmium shares the divalent metal transporter DMT-1 with iron and zinc) and zinc deficiency. Women of reproductive age, who have higher rates of iron deficiency, absorb cadmium more efficiently than men — a factor contributing to higher body burdens in women at equivalent dietary exposure levels. Calcium deficiency also enhances absorption. Fasting increases cadmium uptake.

Metallothionein Binding and Kidney Accumulation

Following absorption, cadmium in blood is bound to albumin and transported to the liver, where it induces synthesis of metallothionein (MT) — a low-molecular-weight cysteine-rich protein that sequesters cadmium and other metals as a protective mechanism. The cadmium-metallothionein complex (Cd-MT) is released into the circulation and filtered at the glomerulus. In the proximal tubule, Cd-MT is reabsorbed and degraded by lysosomal enzymes, releasing free cadmium ions intracellularly. This cycle results in progressive, irreversible accumulation of cadmium in the renal cortex.

Half-Life and Body Burden

The biological half-life of cadmium in the kidney is estimated at 10–30 years in humans. There is no significant excretion mechanism once cadmium is deposited in renal tissue. Urinary cadmium excretion remains very low until renal tubular damage occurs (at which point it increases paradoxically, as the damaged tubule loses its reabsorptive capacity). Total body cadmium increases continuously with age in non-smokers, reaching 15–30 mg in the elderly; smokers accumulate 2–3 times more.

Placental Transfer and Breast Milk

The placenta partially restricts cadmium transfer to the fetus, binding cadmium in placental metallothionein. However, measurable fetal cadmium exposure occurs, and maternal smoking substantially increases fetal cadmium. Cadmium is poorly secreted into breast milk, so breastfeeding does not significantly contribute to infant exposure in the way that some other environmental contaminants do.

Back to Table of Contents

4. Mechanism of Toxicity

Metallothionein Saturation in the Proximal Tubule

The fundamental mechanism of cadmium nephrotoxicity involves saturation of metallothionein binding capacity in proximal tubule cells. When intracellular cadmium exceeds the buffering capacity of metallothionein — which occurs gradually over decades of accumulation — free cadmium ions become available to interact with cellular components. Critical thresholds are estimated at renal cortex cadmium concentrations of approximately 150–200 µg/g wet weight. Beyond this threshold, tubular cell dysfunction and death ensue.

Calcium Metabolism Disruption

Cadmium interferes with calcium homeostasis at multiple levels: it inhibits renal hydroxylation of 25-hydroxyvitamin D to the active 1,25-dihydroxyvitamin D3, reducing intestinal calcium absorption; it directly inhibits calcium transport in the kidney; and it impairs osteoblast function. The result is negative calcium balance and progressive bone demineralization — the mechanism underlying itai-itai disease and cadmium-associated osteoporosis.

Oxidative Stress

Cadmium is not a redox-active metal itself but generates oxidative stress indirectly by depleting glutathione and inhibiting antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase). It displaces copper and iron from proteins, releasing these redox-active metals to participate in Fenton reactions generating hydroxyl radicals. Mitochondrial dysfunction and ROS generation contribute to tubular cell death.

Estrogen Mimicry (Metalloestrogen Activity)

Cadmium has been characterized as a metalloestrogen — it binds to and activates the estrogen receptor alpha (ERα) at nanomolar concentrations without structural similarity to estradiol. This activity may underlie the observed associations between cadmium exposure and hormone-sensitive cancers (breast, endometrial, prostate). Cadmium activates estrogen-responsive gene expression, stimulates proliferation of MCF-7 breast cancer cells in vitro, and has been associated with hormone receptor-positive breast cancer in epidemiological studies.

Zinc Finger Protein Disruption

Cadmium has a strong affinity for thiol and nitrogen ligands, and substitutes for zinc in zinc finger proteins — transcription factors and DNA repair enzymes that coordinate their structure through zinc-cysteine bonds. Cadmium substitution distorts protein structure and impairs function, disrupting gene regulation and DNA repair. This mechanism contributes to cadmium's carcinogenicity by impairing the repair of oxidative DNA damage.

Back to Table of Contents

5. Health Effects

Kidney: Proximal Tubular Dysfunction

The kidney is the critical target organ for chronic cadmium toxicity. The earliest detectable injury is proximal tubular dysfunction, characterized by:

Once established, proximal tubular dysfunction is largely irreversible and may progress to chronic kidney disease (CKD) even after exposure ceases. Population studies in Belgium (the Cadmibel study), Sweden, Japan, and the U.S. (NHANES) consistently link higher urinary cadmium with reduced glomerular filtration rate and incident CKD.

Bone Disease: Itai-Itai and Cadmium Osteoporosis

Cadmium-induced bone disease operates through multiple mechanisms: impaired vitamin D activation reduces calcium absorption, renal tubular dysfunction causes calcium and phosphate wasting, and direct osteotoxicity impairs bone formation. In severe cases (as in itai-itai disease), patients developed osteomalacia with bone pain so severe that any movement caused fractures. In population studies, cadmium exposure at non-occupational levels is associated with reduced bone mineral density, increased fracture risk, and osteoporosis, particularly in postmenopausal women and individuals with nutritional deficiencies.

Cancer

IARC's Group 1 classification for cadmium is based primarily on occupational inhalation studies demonstrating excess lung cancer risk in smelter and battery factory workers. Epidemiological evidence also supports associations with:

Cardiovascular Effects

Epidemiological studies associate urinary cadmium (reflecting body burden) with increased risk of peripheral arterial disease, hypertension, and cardiovascular mortality. Mechanisms include endothelial dysfunction, oxidative stress, inflammation, and disruption of calcium signaling in vascular smooth muscle. The NHANES-based analysis by Tellez-Plaza et al. (2013) identified significant associations between cadmium exposure and cardiovascular mortality even at low exposure levels.

Reproductive and Developmental Effects

Cadmium accumulates in the testis and ovary. Animal studies demonstrate impaired sperm motility, testicular atrophy, and reduced fertility at high doses. In human epidemiological studies, associations between cadmium and reduced semen quality and hormonal disruption have been reported, though findings are less consistent than for kidney or bone effects. Prenatal cadmium exposure has been associated with reduced birth weight and altered neurodevelopment.

Acute Inhalation Toxicity

Acute high-dose inhalation of cadmium oxide fumes (from welding, melting, or smelting cadmium-containing metals) causes a chemical pneumonitis with symptoms appearing 4–24 hours after exposure: fever, cough, chest tightness, and dyspnea that can progress to pulmonary edema and death. This presentation resembles other metal fume fevers but is uniquely life-threatening. A classic case involved early 20th-century electroplaters who died after inhaling cadmium fumes.

Back to Table of Contents

6. Diagnosis

Blood Cadmium (Recent Exposure)

Blood cadmium reflects recent cadmium exposure (primarily from smoking and recent dietary intake) and is a useful indicator of current intake but not of long-term body burden. Normal reference values in non-smoking adults are typically below 0.5 µg/L in the U.S. (NHANES data). Smokers commonly have blood cadmium of 1.0–3.0 µg/L. Blood cadmium is the preferred biomarker when monitoring a known recent exposure or occupational surveillance.

Urine Cadmium (Body Burden)

Urinary cadmium excretion, when corrected for creatinine (expressed as µg/g creatinine), reflects the kidney cadmium body burden and is the preferred biomarker for chronic exposure assessment. Under conditions of intact tubular function, urinary cadmium is proportional to kidney cadmium concentration. Reference values in non-smoking adults are typically below 1.0 µg/g creatinine; occupational biological exposure indices are set at 5 µg/g creatinine (ACGIH BEI). Interpretation requires caution once tubular damage is established, as damaged tubules may paradoxically show elevated urinary cadmium due to impaired reabsorption.

Urine Beta-2 Microglobulin (Early Kidney Damage)

Urinary beta-2 microglobulin (β2M) is a sensitive early marker of proximal tubular dysfunction. Normal urinary β2M is below 300 µg/g creatinine; values above 1000 µg/g creatinine indicate significant tubular impairment. However, β2M is unstable in acidic urine, requiring careful pH control during sample collection and storage. Urinary retinol-binding protein (RBP) and alpha-1 microglobulin are more stable alternatives with similar sensitivity for tubular dysfunction.

Urinary NAG and Tubular Enzymuria

Urinary N-acetyl-β-D-glucosaminidase (NAG) and other lysosomal enzymes are released by cadmium-damaged proximal tubule cells and serve as markers of active tubular injury. These markers may be elevated before β2M rises and can detect subclinical tubular injury in exposed populations.

Bone Mineral Density

DEXA scanning for bone mineral density (BMD) assessment is appropriate in patients with documented high cadmium exposure, particularly postmenopausal women and those with evidence of tubular dysfunction and calcium/phosphate wasting.

Back to Table of Contents

7. Treatment

No Effective Chelation for Chronic Exposure

Unlike lead poisoning, for which chelation therapy can meaningfully reduce body burden and is indicated at high blood lead levels, there is no effective chelation strategy for chronic cadmium toxicity. Standard chelating agents such as EDTA and DMSA do redistribute cadmium from tissues and increase urinary excretion, but they also deliver liberated cadmium to the kidney — worsening renal damage rather than ameliorating it. Clinical use of chelation for cadmium toxicity is not recommended outside of acute high-dose poisoning scenarios. BAL (dimercaprol) is specifically contraindicated for cadmium because it redirects cadmium to the kidney and brain.

Supportive Care

Management of established cadmium nephrotoxicity is supportive and follows general principles of CKD management:

Zinc and Iron Supplementation to Reduce Absorption

Correcting zinc and iron deficiency reduces cadmium absorption through competitive inhibition at DMT-1. In populations with documented iron deficiency and elevated cadmium exposure, iron repletion is an important intervention. Zinc competes with cadmium for intestinal absorption and for metallothionein binding; adequate zinc status is associated with lower cadmium body burden. However, supplementation doses should not greatly exceed recommended daily intakes, as high-dose zinc supplementation carries its own risks (copper deficiency).

Back to Table of Contents

8. Prevention

Smoking Cessation: The Single Most Impactful Intervention

Quitting smoking is far and away the most effective action an individual can take to reduce cadmium exposure. Smokers have 4–7 times higher blood cadmium than non-smokers, and the cumulative kidney cadmium burden in lifelong heavy smokers can approach or exceed thresholds for renal toxicity. Smoking cessation immediately stops the cadmium influx from tobacco and allows blood cadmium to decline, though kidney cadmium (the critical reservoir) remains essentially fixed. Avoiding secondhand smoke also reduces exposure. For occupationally exposed non-smokers, smoking cessation dramatically reduces the total body burden.

Dietary Diversification

No single dietary cadmium source requires elimination in a diversified diet, but individuals with identified high exposure (smokers, those with high rice or shellfish intake) benefit from diversifying their food sources. Practical measures include:

Reducing Dark Chocolate Consumption

Given that dark chocolate is increasingly consumed for perceived cardiovascular benefits, it is worth noting that cadmium (and lead) concentrations vary considerably across products and origin countries. Choosing chocolate sourced from West Africa (generally lower cadmium than South American origins) and moderating intake to one ounce per day reduces cadmium dose substantially.

Occupational Controls

Engineering controls (local exhaust ventilation, enclosed processes, wetting of cadmium-containing dusts) are the primary means of reducing occupational inhalation exposure. Personal protective equipment (air-purifying respirators) provides supplemental protection. Biological monitoring programs allow early detection of elevated body burden before clinical toxicity develops. No eating, drinking, or smoking in cadmium-work areas prevents secondary ingestion exposure.

Regulatory and Agricultural Measures

Long-term reduction of dietary cadmium requires soil-level interventions: reducing cadmium content in phosphate fertilizers, liming acidic soils (raising pH reduces cadmium bioavailability to plants), breeding low-cadmium crop varieties (active research in rice and wheat), and remediating cadmium-contaminated farmland. The EU, Japan, and Australia have established maximum cadmium limits in food, fertilizer, and soil, providing regulatory frameworks that drive industrial and agricultural practice.

Back to Table of Contents

Back to Table of Contents

10. References

  1. International Agency for Research on Cancer. Cadmium and cadmium compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 100C. Lyon: IARC; 2012. https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100C-8.pdf
  2. Järup L, Åkesson A. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol. 2009;238(3):201–208. https://doi.org/10.1016/j.taap.2009.04.020
  3. Itai K, et al. Renal tubular dysfunction caused by environmental cadmium exposure in the general Japanese population. Environ Health Perspect. 1998;106(4):153–158. https://doi.org/10.1289/ehp.98106153
  4. Suwazono Y, et al. Long-term cadmium exposure and mortality among inhabitants in the cadmium-polluted Kakehashi River Basin in Japan. Sci Total Environ. 2009;407(18):5129–5134. https://doi.org/10.1016/j.scitotenv.2009.05.041
  5. Staessen JA, et al. Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med. 1992;327(3):151–156. https://doi.org/10.1056/NEJM199207163270302
  6. Nawrot TS, et al. Cadmium exposure in the population: from health risks to strategies of prevention. Biometals. 2010;23(5):769–782. https://doi.org/10.1007/s10534-010-9343-z
  7. Åkesson A, et al. Low-level cadmium exposure stimulates bone resorption and decreases tubular reabsorption of calcium in elderly women. Bone. 2006;38(2):219–224. https://doi.org/10.1016/j.bone.2005.08.025
  8. Brama M, et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland of rats. Nat Med. 2002;8(10):1134–1139. https://doi.org/10.1038/nm771
  9. Tellez-Plaza M, et al. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect. 2012;120(7):1017–1022. https://doi.org/10.1289/ehp.1104352
  10. Gallagher CM, Kovach JS, Meliker JR. Urinary cadmium and osteoporosis in U.S. women ≥50 years of age: NHANES 1988–1994 and 1999–2004. Environ Health Perspect. 2008;116(10):1338–1343. https://doi.org/10.1289/ehp.11452
  11. Nishijo M, et al. Causes of death and renal tubular dysfunction in residents of a cadmium-polluted area in Japan. Occup Environ Med. 2006;63(8):545–550. https://doi.org/10.1136/oem.2005.024398
  12. European Food Safety Authority. Cadmium dietary exposure in the European population. EFSA Journal. 2012;10(1):2551. https://doi.org/10.2903/j.efsa.2012.2551
  13. Satarug S, Gobe GC, Vesey DA, Phelps KR. Cadmium and lead exposure, nephrotoxicity, and mortality. Toxics. 2020;8(4):86. https://doi.org/10.3390/toxics8040086
  14. Nordberg GF, et al. Cadmium and human health: a perspective based on current knowledge. Arch Toxicol. 2018;92(5):1652. https://doi.org/10.1007/s00204-018-2127-4
  15. Jin T, Nordberg G, Ye T, et al. Osteoporosis and renal dysfunction in a general population exposed to cadmium in China. Environ Res. 2004;96(3):353–359. https://doi.org/10.1016/j.envres.2003.10.001
  16. Hartwig A. Cadmium and cancer. Met Ions Life Sci. 2013;11:491–507. https://doi.org/10.1007/978-94-007-5179-8_15
  17. Prozialeck WC, Edwards JR. Mechanisms of cadmium-induced proximal tubule injury: new insights with implications for biomonitoring and therapeutic interventions. J Pharmacol Exp Ther. 2012;343(1):2–12. https://doi.org/10.1124/jpet.110.166769
  18. Vahter M, et al. Associations between cadmium exposure and oxidative stress, inflammation and diabetes in men. Environ Res. 2007;103(3):370–377. https://doi.org/10.1016/j.envres.2006.11.003

Back to Table of Contents